SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-047043
Filing Date
2024-04-23
Accepted
2024-04-23 17:05:06
Documents
10
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A allk-def_14a-2024_proxy_.htm DEF 14A 1289489
2 GRAPHIC img146554756_0.jpg GRAPHIC 22482
3 GRAPHIC img146554756_1.jpg GRAPHIC 3558
4 GRAPHIC img146554756_2.jpg GRAPHIC 3558
5 GRAPHIC img146554756_3.jpg GRAPHIC 41814
6 GRAPHIC img146554756_4.jpg GRAPHIC 43117
7 GRAPHIC img146554756_5.jpg GRAPHIC 280759
8 GRAPHIC img146554756_6.jpg GRAPHIC 299687
9 GRAPHIC img146554756_7.jpg GRAPHIC 1345760
10 GRAPHIC img146554756_8.jpg GRAPHIC 137573
  Complete submission text file 0000950170-24-047043.txt   4288851
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38582 | Film No.: 24865632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)